Could a Once-Daily steroid pill improve blood sugar control in Dual-Disease patients?

NCT ID NCT05716607

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether taking hydrocortisone once a day (as a dual-release pill) leads to more stable blood sugar levels compared to the standard three-times-a-day regimen in adults who have both insulin-treated diabetes and Addison's disease. Participants will try both schedules in a random order, and researchers will track glucose patterns, HbA1c, and cortisol levels. The goal is to find a dosing strategy that simplifies treatment while improving glycemic control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Once-daily dual-release hydrocortisone vs thrice-daily immediate-release hydrocortisone
What this could lead to
If it works, this could point toward a simpler, more effective hydrocortisone dosing schedule for people with both diabetes and Addison's disease, potentially improving blood sugar control.
What could go wrong
This is a small, early-stage crossover trial, so results may not apply to everyone. The benefit of once-daily dosing may be modest or absent, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDISON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sahlgrenska University Hospital

    Gothenburg, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.